Morgan Stanley’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $168K | Sell |
228,638
-623,734
| -73% | -$457K | ﹤0.01% | 5919 |
|
|
2025
Q1 | $852K | Buy |
852,372
+120,960
| +17% | +$121K | ﹤0.01% | 5080 |
|
|
2024
Q4 | $7.75M | Buy |
731,412
+377,721
| +107% | +$4M | ﹤0.01% | 3619 |
|
|
2024
Q3 | $4.67M | Buy |
353,691
+196,953
| +126% | +$2.6M | ﹤0.01% | 4011 |
|
|
2024
Q2 | $1.54M | Buy |
156,738
+91,363
| +140% | +$898K | ﹤0.01% | 4719 |
|
|
2024
Q1 | $899K | Buy |
65,375
+3,217
| +5% | +$44.2K | ﹤0.01% | 5016 |
|
|
2023
Q4 | $1.06M | Buy |
62,158
+61,758
| +15,440% | +$1.05M | ﹤0.01% | 5263 |
|
|
2023
Q3 | $5.64K | Buy |
+400
| New | +$5.64K | ﹤0.01% | 6885 |
|